In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

HealthDay News — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in the ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

Having the flu is a lousy experience, regardless of the type you have. While news of a rough flu season ahead (spurred by subclade K) continues to make headlines, there are two main types of flu, A ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

It has been said that the U.S. doesn’t have a healthcare system; but rather a disease management system We wait until diseases occur and then spend trillions of dollars trying to manage them, ...

Public health experts say people should still get the vaccine – and as soon as possible – as it will still provide protection ...

Pregnant women and adults over 75 among priority groups for RSV protection as respiratory virus season approaches in Ohio.

With the arrival of winter, the Dominican Republic has seen a significant increase in respiratory viruses, especially influenza A and B, which cause the flu. Given this situation, the question arises: ...